Education
About Us
Working with TipRanks
Follow Us
Thiogenesis Therapeutics Corp (TSE:TTI)
:TTI
TTI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.50 - C$0.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)35.29K
Market Cap
C$32.88M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding46,306,890
10 Day Avg. Volume24,700
30 Day Avg. Volume35,286
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Thiogenesis Therapeutics Corp News
PremiumCompany Announcements
Thiogenesis Launches Phase 2 Trial for MELAS Treatment
PremiumCompany Announcements
Thiogenesis Expands European Reach with New Consultancy Agreement
PremiumCompany Announcements
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
PremiumCompany Announcements
Thiogenesis to Launch Phase 2 Trial for MELAS Treatment
PremiumCompany Announcements
Thiogenesis Therapeutics Advances in Mitochondrial Disease Trials
PremiumCompany Announcements
Thiogenesis Gains DTC Eligibility and Expands U.S. Presence
PremiumCompany Announcements
Thiogenesis Secures Key European Patent
PremiumCompany Announcements
Thiogenesis Boosts Investor Relations with New PartnershipOptions Prices
Currently, No data available
---
Ownership Overview
14.62% Insiders
―
Mutual Funds
― Other Institutional Investors
85.38% Public Companies and
Individual Investors
TTI FAQ
What was Thiogenesis Therapeutics Corp’s price range in the past 12 months?
Thiogenesis Therapeutics Corp lowest stock price was C$0.50 and its highest was C$0.80 in the past 12 months.
What is Thiogenesis Therapeutics Corp’s market cap?
Thiogenesis Therapeutics Corp’s market cap is C$32.88M.
When is Thiogenesis Therapeutics Corp’s upcoming earnings report date?
Thiogenesis Therapeutics Corp’s upcoming earnings report date is Aug 21, 2025 which is in 74 days.
How were Thiogenesis Therapeutics Corp’s earnings last quarter?
Currently, no data Available
Is Thiogenesis Therapeutics Corp overvalued?
According to Wall Street analysts Thiogenesis Therapeutics Corp’s price is currently Overvalued.
Does Thiogenesis Therapeutics Corp pay dividends?
Thiogenesis Therapeutics Corp does not currently pay dividends.
What is Thiogenesis Therapeutics Corp’s EPS estimate?
Thiogenesis Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thiogenesis Therapeutics Corp have?
Thiogenesis Therapeutics Corp has 46,306,890 shares outstanding.
What happened to Thiogenesis Therapeutics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Thiogenesis Therapeutics Corp?
Currently, no hedge funds are holding shares in TSE:TTI
Company Description
Thiogenesis Therapeutics Corp
Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.
Technical Analysis
Rapid Dose Therapeutics Corp
―
Helix BioPharma
―
PharmaTher Holdings Ltd
―
NurExone Biologic
―
Glow LifeTech
―